JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


Anesth Analg 2009; 109:1949-1961
© 2009 International Anesthesia Research Society
doi: 10.1213/ANE.0b013e3181b845d0
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow CME: Take the course for this article:
Course on Management of Adult Patients with Cystic Fibrosis
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Huffmyer, J. L.
Right arrow Articles by Nemergut, E. C.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Huffmyer, J. L.
Right arrow Articles by Nemergut, E. C.
Related Collections
Right arrow Preoperative Evaluation
Right arrow Patient Safety
Right arrow General
Right arrow Pediatrics


GENERAL ARTICLE

Perioperative Management of the Adult with Cystic Fibrosis

Julie L. Huffmyer, MD, Keith E. Littlewood, MD, and Edward C. Nemergut, MD

From the Department of Anesthesiology, University of Virginia Health System, Charlottesville, Virginia.

Address correspondence to Edward C. Nemergut, MD, Department of Anesthesiology, University of Virginia Health System, PO Box 800710, Charlottesville, VA 22908-0710. Address e-mail to en3x{at}virginia.edu.

Since cystic fibrosis (CF) was first differentiated from celiac disease in 1938, the medical care of patients with CF has substantially improved. These improvements have resulted in a significant increase in median survival and the quality of life experienced by patients. The resultant increase in survival has caused the "average" CF patient to be a young adult and not a child. The gene that causes CF was first identified in 1989 and is the first gene discovered by positional cloning. Unfortunately, gene therapy for CF has not been successful, although it continues to hold great promise for future patient care. Although pulmonary disease is responsible for more than 90% of the morbidity and mortality in patients with CF, they also experience pancreatic disease, including diabetes mellitus, bone disease, hepatobiliary disease, and genitourinary disease. The optimal perioperative management of patients with CF requires an understanding of the relevant pathophysiology and the unique challenges presented by these patients. We reviewed these concepts, including special considerations such as liver and lung transplantation and pregnancy.







Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins and Stanford University Libraries' HighWire Press®. Copyright 2009 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2009 by the International Anesthesia Research Society.